Advanced Cell Technology gets 2 patents related to retinal cells

09/15/2010 | Mass High Tech (Boston)

Advanced Cell Technology has received a patent to use retinal pigment epithelial cells derived from human embryonic stem cells in the treatment of retinal degeneration. The company also received another patent that allows it to produce RPE cells for use in transplantation. The patents will enable the company to test its cell treatment for Stargardt's disease.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD